Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis
Clinical trial NCT03055195 · TERMINATED
Trial details
- NCT number
- NCT03055195
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-21
- Primary completion
- 2017-12-06
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.